Rasagiline is a selective, irreversible monoamine oxidase B (MAO-B) inhibitor used to treat Parkinson's disease. Although its overall tolerance is good, some patients may experience headaches, joint pain, and indigestion. The following are targeted management suggestions.

1、 Coping strategies for headaches

1.1 Characteristics of occurrence

Headache is a common side effect in the early treatment of rasagiline, often mild to moderate, and usually appears within a few days after medication. It can gradually alleviate with continued treatment.

1.2 Suggestions for Handling

Adjusting medication timing: Taking rasagiline with breakfast can reduce vascular reactive headaches caused by fasting medication.

Short term symptomatic treatment: Under the guidance of a doctor, acetaminophen (paracetamol) can be used to relieve headaches, but avoid using drugs containing triptans or opioids to increase the risk of serotonin syndrome.

Monitoring blood pressure: Reshapil may affect blood pressure, and headache sufferers should investigate whether it is induced by orthostatic hypotension.

Persistent or severe headache: If the headache persists for more than 1 week or worsens progressively, Parkinson's disease progression or other drug interactions need to be reassessed.

2、 Relief measures for joint pain

2.1 Characteristics of occurrence

Joint pain is a rare but quality of life adverse reaction of rasagiline, often manifested as soreness in the knee, wrist, or shoulder joints.

2.2 Suggestions for Handling

Non pharmacological treatment: Warm compress, low-intensity aerobic exercise (such as walking, swimming), and joint range of motion training can improve local circulation, alleviate morning stiffness and pain.

Drug intervention: Under the guidance of neurologists, non steroidal anti-inflammatory drugs (NSAIDs) can be selected for short-term external use (such as diclofenac gel) or oral use (such as ibuprofen), but the gastrointestinal and cardiovascular risks should be alert.

Avoid long-term abuse of NSAIDs: If joint pain persists for more than 2 weeks or does not improve after medication, consideration should be given to whether it is accompanied by osteoarthritis, gout, or rheumatoid arthritis, and if necessary, referral to a rheumatology and immunology department for evaluation.

3、 Adjustment plan for indigestion

3.1 Characteristics of occurrence

Dyspepsia can be seen in the use of rasagiline, manifested as upper abdominal fullness, belching, acid reflux, or nausea, often related to the effects of medication on gastrointestinal motility and fasting.

3.2 Suggestions for Handling

Medication adjustment: It is recommended to take rasagiline with meals to reduce direct irritation to the gastric mucosa.

Dietary management: Eat small meals frequently, avoid high-fat, spicy, and overly sweet foods, and reduce caffeine and alcohol intake.

Adjuvant medication: Short term use of antacids (such as magnesium aluminum carbonate) or H2 receptor antagonists (such as famotidine) can alleviate symptoms, but attention should be paid to potential interactions with rasagiline (preferably taken at intervals of ≥ 2 hours).

Assessment of Helicobacter pylori or gastritis: If indigestion persists, Helicobacter pylori testing or gastroscopy should be performed to rule out concomitant gastrointestinal lesions.